Determinants of mTOR inhibitor therapy in AIDS-associated malignancies

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1750-9378

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Determinants of mTOR inhibitor therapy in AIDS-associated malignancies ; volume:7 ; number:1 ; day:19 ; month:4 ; year:2012 ; pages:1 ; date:12.2012
Infectious agents and cancer ; 7, Heft 1 (19.4.2012), 1, 12.2012

Creator: Dittmer, Dirk P.

Contributor: Damania, Blossom
Sin, Sang-Hoon
Roy, Debasmita
SpringerLink (Online service)

DOI: 10.1186/1750-9378-7-S1-O9

URN: urn:nbn:de:1111-2016072625933

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 28.09.0020, 8:22 PM CET

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Dittmer, Dirk P.
Damania, Blossom
Sin, Sang-Hoon
Roy, Debasmita
SpringerLink (Online service)

Other Objects (12)

Checkpoint inhibitors in hematological malignancies

Deptor: not only a mTOR inhibitor

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges

Genetic Analysis of HIV in AIDS Malignancies

mTor Inhibitors for the Treatment of Endometriosis

mTOR inhibitors as radiosensitizers in neuroendocrine neoplasms

Hochschulschrift

Zelltod-Regulation durch mTOR Inhibitor Everolimus im Nierenzellkarzinom

Clinical development of mTOR inhibitors in breast cancer

Practical considerations for the use of mTOR inhibitors

mTOR inhibitor everolimus reduces invasiveness of melanoma cells

mTOR inhibitor Everolimus-induced apoptosis in melanoma cells

Perfect match: mTOR inhibitors and tuberous sclerosis complex

Checkpoint inhibitors in hematological malignancies

Deptor: not only a mTOR inhibitor

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges

Genetic Analysis of HIV in AIDS Malignancies

mTor Inhibitors for the Treatment of Endometriosis

mTOR inhibitors as radiosensitizers in neuroendocrine neoplasms

Hochschulschrift

Zelltod-Regulation durch mTOR Inhibitor Everolimus im Nierenzellkarzinom

Clinical development of mTOR inhibitors in breast cancer

Practical considerations for the use of mTOR inhibitors

mTOR inhibitor everolimus reduces invasiveness of melanoma cells

mTOR inhibitor Everolimus-induced apoptosis in melanoma cells

Perfect match: mTOR inhibitors and tuberous sclerosis complex

Checkpoint inhibitors in hematological malignancies

Deptor: not only a mTOR inhibitor

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges

Genetic Analysis of HIV in AIDS Malignancies

mTor Inhibitors for the Treatment of Endometriosis

mTOR inhibitors as radiosensitizers in neuroendocrine neoplasms

Hochschulschrift

Zelltod-Regulation durch mTOR Inhibitor Everolimus im Nierenzellkarzinom

Clinical development of mTOR inhibitors in breast cancer

Practical considerations for the use of mTOR inhibitors

mTOR inhibitor everolimus reduces invasiveness of melanoma cells

mTOR inhibitor Everolimus-induced apoptosis in melanoma cells

Perfect match: mTOR inhibitors and tuberous sclerosis complex

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Determinants of mTOR inhibitor therapy in AIDS-associated malignancies

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Checkpoint inhibitors in hematological malignancies

Deptor: not only a mTOR inhibitor

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges

Genetic Analysis of HIV in AIDS Malignancies

mTor Inhibitors for the Treatment of Endometriosis

mTOR inhibitors as radiosensitizers in neuroendocrine neoplasms

Zelltod-Regulation durch mTOR Inhibitor Everolimus im Nierenzellkarzinom

Clinical development of mTOR inhibitors in breast cancer

Practical considerations for the use of mTOR inhibitors

mTOR inhibitor everolimus reduces invasiveness of melanoma cells

mTOR inhibitor Everolimus-induced apoptosis in melanoma cells

Perfect match: mTOR inhibitors and tuberous sclerosis complex

Checkpoint inhibitors in hematological malignancies

Deptor: not only a mTOR inhibitor

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges

Genetic Analysis of HIV in AIDS Malignancies

mTor Inhibitors for the Treatment of Endometriosis

mTOR inhibitors as radiosensitizers in neuroendocrine neoplasms

Zelltod-Regulation durch mTOR Inhibitor Everolimus im Nierenzellkarzinom

Clinical development of mTOR inhibitors in breast cancer

Practical considerations for the use of mTOR inhibitors

mTOR inhibitor everolimus reduces invasiveness of melanoma cells

mTOR inhibitor Everolimus-induced apoptosis in melanoma cells

Perfect match: mTOR inhibitors and tuberous sclerosis complex

Checkpoint inhibitors in hematological malignancies

Deptor: not only a mTOR inhibitor

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges

Genetic Analysis of HIV in AIDS Malignancies

mTor Inhibitors for the Treatment of Endometriosis

mTOR inhibitors as radiosensitizers in neuroendocrine neoplasms

Zelltod-Regulation durch mTOR Inhibitor Everolimus im Nierenzellkarzinom

Clinical development of mTOR inhibitors in breast cancer

Practical considerations for the use of mTOR inhibitors

mTOR inhibitor everolimus reduces invasiveness of melanoma cells

mTOR inhibitor Everolimus-induced apoptosis in melanoma cells

Perfect match: mTOR inhibitors and tuberous sclerosis complex

Related objects

Reset password